|
|
Volumn 18, Issue 1, 2003, Pages 1-3
|
|
Essential medicines twenty-five years on: Closing the access gap
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ESSENTIAL DRUG;
GENERIC DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFRICA;
COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DIABETES MELLITUS;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULARY;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MONITORING;
DRUG SAFETY;
ECONOMIC ASPECT;
EDITORIAL;
FEMALE;
GOOD MANUFACTURING PRACTICE;
GOVERNMENT;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HEALTH CARE FINANCING;
HEALTH CARE NEED;
HEALTH CARE POLICY;
HEALTH EDUCATION;
HEALTH INSURANCE;
HEALTH PROMOTION;
HEALTH SERVICE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
INDUSTRIALIZATION;
INTERNATIONAL COOPERATION;
MALARIA;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIMARY HEALTH CARE;
REIMBURSEMENT;
SOCIAL ASPECT;
STANDARD;
TUBERCULOSIS;
UNIVERSITY HOSPITAL;
DRUGS, ESSENTIAL;
HEALTH POLICY;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
PRIMARY HEALTH CARE;
WORLD HEALTH;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0037374046
PISSN: 02681080
EISSN: None
Source Type: Journal
DOI: 10.1093/heapol/18.1.1 Document Type: Editorial |
|
Times cited : (37)
|
|
References (0)
|
